In Depth 1 Jul 2025 Is an HIV cure possible? The future of HIV therapy …receptor that HIV uses to enter immune cells. Following the transplant, his immune system was rebuilt with HIV-resistant cells. He stopped antiretroviral therapy and remained virus-free for the rest of… July 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 24 Apr 2024 Overcoming toxicities: are IL-2 smart cytokines the next big thing? …(FDA) for the treatment of mucosal melanoma, a type of rare and aggressive cancer that begins in the tissues that line organs. It has also gained the fast track designation… April 24, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2022 The challenges of translating CRISPR to the clinic …the patient-derived T-cells themselves which are used to make the CAR-T medicine are compromised. This is due to the T-cells being derived from patients who have received a toxic preconditioning… October 17, 2022 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jul 2023 Lung cancer research: five advancements over the past year …appropriate for them because of poor tolerance or toxicity concerns, leaving them with limited treatment options. Added to that, most treatment guidelines currently do not recommend immunotherapy treatment due to… July 10, 2023 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Apr 2024 8 of the most expensive drugs in biopharma: Unraveling the costliest medications …shock to many, bluebird said that it works out cheaper than current beta-thalassemia treatment options. At the time of its approval, Zynteglo became the first cell-based gene therapy for the… April 25, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022 Promising drug candidate discovered for prevention of type 1 diabetes …TYK2 inhibitor. This drug molecule has already been approved in the United States for the treatment of psoriasis,” Otonkoski notes. According to Otonkoski, the effect of TYK2 inhibitors in the… November 10, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 19 May 2022 Evotec, Sernova in partnership to develop beta cell diabetes therapy …are a type of pluripotent stem cell that can be generated directly from adult cells. It’s their ability to propagate indefinitely that has led scientists to hold out hope for… May 19, 2022 - 3 minutesmins - By Susannah Rodgers Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2025 Pushing biotech forward in France: 18 companies to know about …body’s own cells, the patient’s body does not normally attack them. But OncoMimics trick the immune system by presenting bacterial peptides from the microbiome that closely resemble tumor antigens, but… June 10, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Interview 5 Dec 2018 How Automation Will Enable the Age of Cell Therapy …100 scientists from different companies and labs and they told us that [cell culture] was the number one thing that was taking their time to do manually,” he says. They… December 5, 2018 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 6 Sep 2017 The CAR-T Race is Far from Over: This CEO is Exploring a New Avenue …launched in 2007, it wasn’t a CAR-T product but naturally occurring T cells targeting viral antigens for the treatment of infections. The company then used this technology to target cancers… September 6, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2022 Continuous cell culture paves the way for better biomanufacturing …the blood of calves. These cells need to attach to a surface in order to grow, and the technology also facilitates the detachment of cells from the bioreactor to harvest… July 1, 2022 - 6 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 May 2024 Biotech in New Jersey: Nine companies leading the charge …into the host cell genome, to create treatments for diseases that have historically had limited treatment options. Rocket’s therapeutic pipeline includes projects targeting Fanconi anemia (FA), leukocyte adhesion deficiency type… May 7, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email